(INGR) Ingredion - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4571871023

Sweeteners, Starches, Corn Oil, Gluten Feed, Biomaterials

EPS (Earnings per Share)

EPS (Earnings per Share) of INGR over the last years for every Quarter: "2020-12": 1.75, "2021-03": 1.85, "2021-06": 2.05, "2021-09": 1.67, "2021-12": 1.09, "2022-03": 1.95, "2022-06": 2.12, "2022-09": 1.73, "2022-12": 1.65, "2023-03": 2.8, "2023-06": 2.32, "2023-09": 2.33, "2023-12": 1.97, "2024-03": 2.08, "2024-06": 2.87, "2024-09": 3.05, "2024-12": 2.63, "2025-03": 2.97, "2025-06": 2.87, "2025-09": 2.75, "2025-12": 0,

Revenue

Revenue of INGR over the last years for every Quarter: 2020-12: 1593, 2021-03: 1614, 2021-06: 1762, 2021-09: 1763, 2021-12: 1755, 2022-03: 1892, 2022-06: 2044, 2022-09: 2023, 2022-12: 1987, 2023-03: 2137, 2023-06: 2069, 2023-09: 2033, 2023-12: 1921, 2024-03: 1882, 2024-06: 1878, 2024-09: 1870, 2024-12: 1800, 2025-03: 1813, 2025-06: 1833, 2025-09: 1816, 2025-12: null,

Dividends

Dividend Yield 2.85%
Yield on Cost 5y 4.69%
Yield CAGR 5y 5.70%
Payout Consistency 97.8%
Payout Ratio 28.9%
Risk via 5d forecast
Volatility 19.2%
Value at Risk 5%th 29.1%
Relative Tail Risk -7.98%
Reward TTM
Sharpe Ratio -0.81
Alpha -20.99
CAGR/Max DD 0.24
Character TTM
Hurst Exponent 0.473
Beta 0.310
Beta Downside 0.261
Drawdowns 3y
Max DD 29.95%
Mean DD 8.65%
Median DD 6.55%

Description: INGR Ingredion January 06, 2026

Ingredion Incorporated (NYSE: INGR) manufactures and markets a broad portfolio of corn-derived ingredients-including sweeteners, starches, nutrition ingredients, and biomaterial solutions-serving food & beverage, paper, textile, construction, pharmaceutical, and specialty chemical markets worldwide.

Key operating metrics that investors watch include the company’s FY 2024 revenue of roughly $6.3 billion, an adjusted EBITDA margin near 12 %, and a free-cash-flow conversion rate of ~80 % of EBITDA, reflecting strong cash generation. The business is highly sensitive to corn commodity prices and global food-security trends; a 10 % rise in corn costs historically depresses gross margins by ~0.5 %-0.7 % while rising demand for plant-based proteins and biodegradable plastics offers a secular growth tailwind.

For a deeper dive into Ingredion’s valuation dynamics and peer comparison, you may find ValueRay’s analytical tools useful.

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (659.0m TTM) > 0 and > 6% of Revenue (6% = 435.7m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA -4.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 30.82% (prev 27.76%; Δ 3.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 975.0m > Net Income 659.0m (YES >=105%, WARN >=100%)
Net Debt (883.0m) to EBITDA (1.18b) ratio: 0.75 <= 3.0 (WARN <= 3.5)
Current Ratio 2.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (65.4m) change vs 12m ago -1.65% (target <= -2.0% for YES)
Gross Margin 25.43% (prev 23.07%; Δ 2.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 94.57% (prev 100.3%; Δ -5.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 25.84 (EBITDA TTM 1.18b / Interest Expense TTM 37.0m) >= 6 (WARN >= 3)

Altman Z'' 6.34

(A) 0.29 = (Total Current Assets 3.52b - Total Current Liabilities 1.28b) / Total Assets 7.83b
(B) 0.70 = Retained Earnings (Balance) 5.50b / Total Assets 7.83b
(C) 0.12 = EBIT TTM 956.0m / Avg Total Assets 7.68b
(D) 1.28 = Book Value of Equity 4.55b / Total Liabilities 3.57b
Total Rating: 6.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 68.70

1. Piotroski 6.50pt
2. FCF Yield 10.60%
3. FCF Margin 11.62%
4. Debt/Equity 0.42
5. Debt/Ebitda 0.75
6. ROIC - WACC (= 5.86)%
7. RoE 16.10%
8. Rev. Trend -44.27%
9. EPS Trend -10.91%

What is the price of INGR shares?

As of January 11, 2026, the stock is trading at USD 113.57 with a total of 407,636 shares traded.
Over the past week, the price has changed by +3.44%, over one month by +7.66%, over three months by -4.29% and over the past year by -10.89%.

Is INGR a buy, sell or hold?

Ingredion has received a consensus analysts rating of 3.43. Therefor, it is recommend to hold INGR.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the INGR price?

Issuer Target Up/Down from current
Wallstreet Target Price 124.3 9.5%
Analysts Target Price 124.3 9.5%
ValueRay Target Price 121.2 6.7%

INGR Fundamental Data Overview January 09, 2026

P/E Trailing = 11.0955
P/E Forward = 9.7087
P/S = 0.9757
P/B = 1.6326
P/EG = 1.1559
Beta = 0.711
Revenue TTM = 7.26b USD
EBIT TTM = 956.0m USD
EBITDA TTM = 1.18b USD
Long Term Debt = 1.74b USD (from longTermDebt, last quarter)
Short Term Debt = 57.0m USD (from shortTermDebt, last quarter)
Debt = 1.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 883.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.96b USD (7.09b + Debt 1.80b - CCE 921.0m)
Interest Coverage Ratio = 25.84 (Ebit TTM 956.0m / Interest Expense TTM 37.0m)
EV/FCF = 9.43x (Enterprise Value 7.96b / FCF TTM 844.0m)
FCF Yield = 10.60% (FCF TTM 844.0m / Enterprise Value 7.96b)
FCF Margin = 11.62% (FCF TTM 844.0m / Revenue TTM 7.26b)
Net Margin = 9.07% (Net Income TTM 659.0m / Revenue TTM 7.26b)
Gross Margin = 25.43% ((Revenue TTM 7.26b - Cost of Revenue TTM 5.42b) / Revenue TTM)
Gross Margin QoQ = 25.06% (prev 26.02%)
Tobins Q-Ratio = 1.02 (Enterprise Value 7.96b / Total Assets 7.83b)
Interest Expense / Debt = 0.39% (Interest Expense 7.00m / Debt 1.80b)
Taxrate = 28.63% (69.0m / 241.0m)
NOPAT = 682.3m (EBIT 956.0m * (1 - 28.63%))
Current Ratio = 2.75 (Total Current Assets 3.52b / Total Current Liabilities 1.28b)
Debt / Equity = 0.42 (Debt 1.80b / totalStockholderEquity, last quarter 4.24b)
Debt / EBITDA = 0.75 (Net Debt 883.0m / EBITDA 1.18b)
Debt / FCF = 1.05 (Net Debt 883.0m / FCF TTM 844.0m)
Total Stockholder Equity = 4.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.58% (Net Income 659.0m / Total Assets 7.83b)
RoE = 16.10% (Net Income TTM 659.0m / Total Stockholder Equity 4.09b)
RoCE = 16.39% (EBIT 956.0m / Capital Employed (Equity 4.09b + L.T.Debt 1.74b))
RoIC = 11.55% (NOPAT 682.3m / Invested Capital 5.91b)
WACC = 5.69% (E(7.09b)/V(8.88b) * Re(7.06%) + D(1.80b)/V(8.88b) * Rd(0.39%) * (1-Tc(0.29)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.76%
[DCF Debug] Terminal Value 83.75% ; FCFF base≈969.2m ; Y1≈774.3m ; Y5≈523.4m
Fair Price DCF = 239.4 (EV 16.09b - Net Debt 883.0m = Equity 15.21b / Shares 63.5m; r=5.90% [WACC]; 5y FCF grow -24.05% → 2.90% )
EPS Correlation: -10.91 | EPS CAGR: -44.96% | SUE: -4.0 | # QB: 0
Revenue Correlation: -44.27 | Revenue CAGR: 0.92% | SUE: -2.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.78 | Chg30d=-0.019 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=11.39 | Chg30d=-0.008 | Revisions Net=-6 | Growth EPS=+1.8% | Growth Revenue=+1.0%

Additional Sources for INGR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle